A detailed history of Fmr LLC transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 4,415,218 shares of LBPH stock, worth $264 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,415,218
Previous 4,525,070 2.43%
Holding current value
$264 Million
Previous $97.7 Million 22.1%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$17.0 - $27.03 $1.87 Million - $2.97 Million
-109,852 Reduced 2.43%
4,415,218 $119 Million
Q1 2024

May 13, 2024

BUY
$18.89 - $26.06 $54.3 Million - $74.9 Million
2,875,567 Added 174.33%
4,525,070 $97.7 Million
Q4 2023

Feb 13, 2024

SELL
$3.68 - $6.5 $1.71 Million - $3.01 Million
-463,570 Reduced 21.94%
1,649,503 $9.95 Million
Q3 2023

Nov 13, 2023

SELL
$5.49 - $7.49 $2.5 Million - $3.42 Million
-456,084 Reduced 17.75%
2,113,073 $11.7 Million
Q2 2023

Aug 11, 2023

SELL
$4.19 - $10.05 $1.39 Million - $3.33 Million
-331,235 Reduced 11.42%
2,569,157 $18.9 Million
Q1 2023

May 11, 2023

BUY
$3.84 - $5.96 $6.89 Million - $10.7 Million
1,795,488 Added 162.5%
2,900,392 $11.6 Million
Q4 2022

Feb 13, 2023

BUY
$2.95 - $5.5 $629,541 - $1.17 Million
213,404 Added 23.94%
1,104,904 $3.6 Million
Q3 2022

Nov 10, 2022

SELL
$2.95 - $4.7 $17 - $28
-6 Reduced -0.0%
891,500 $3.32 Million
Q2 2022

Aug 12, 2022

SELL
$2.96 - $5.38 $466,069 - $847,113
-157,456 Reduced 15.01%
891,506 $2.76 Million
Q1 2022

May 13, 2022

SELL
$4.0 - $6.0 $1.87 Million - $2.8 Million
-466,621 Reduced 30.79%
1,048,962 $5.45 Million
Q4 2021

Feb 14, 2022

SELL
$4.75 - $9.45 $822,880 - $1.64 Million
-173,238 Reduced 10.26%
1,515,583 $7.34 Million
Q3 2021

Nov 15, 2021

SELL
$8.65 - $11.36 $3.02 Million - $3.96 Million
-349,010 Reduced 17.13%
1,688,821 $14.9 Million
Q2 2021

Aug 13, 2021

BUY
$7.95 - $17.3 $16.2 Million - $35.3 Million
2,037,831 New
2,037,831 $18.6 Million

Others Institutions Holding LBPH

About Longboard Pharmaceuticals, Inc.


  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $811M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.